Jubilant Pharmova Limited (JUBLPHARMA) — Corporate Action | 30 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Notice of transfer of equity shares and dividend to Investor Education and Protection Fund Authority published.
💡 Investor Takeaway
Shareholders should verify dividend and transfer details on the company's website.

Jubilant Pharmova announced that a notice of transfer of equity shares and dividend to the Investor Education and Protection Fund Authority was published in Financial Express and Hindustan & Jansatta on July 30, 2026, and will be posted on its website.

📄 View Original Announcement (PDF)

About Jubilant Pharmova Limited (JUBLPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹14,469.9 Cr P/E: 40.9 ROE: 5.0% ROCE: 7.4% Div Yield: 0.55%

View full JUBLPHARMA stock details →

📡 Get AI alerts when JUBLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLPHARMA — Free

📊 More JUBLPHARMA filings

See all JUBLPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLPHARMA files new disclosures

Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JUBLPHARMA — Free

Free account · 2 AI queries/day